Skip to main content

Fact Sheet - Safer insulin prescribing

This factsheet outlines the critical safety elements for safer insulin prescribing within the context of active ingredient prescribing. As prescriptions are generated with the active ingredient name, prescribers should check the brand name is included. Inclusion of insulin brand name supports safer product identification and selection.

Downloads

Fact Sheet - Safer insulin prescribing

Download PDF (314.93 KB)
Download Word (123.03 KB)

Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.

Complete this form to request permission to reproduce material produced by the Commission.

 

Publication year
2022
Resource type
Fact sheet or brochure
Back to top